Zongwen Liu

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.

Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.

Journal: BMC medical imaging
Published: July 18, 2025

Effect of exercise rehabilitation during neoadjuvant chemotherapy before esophageal cancer surgery on perioperative outcomes: A systematic review and meta-analysis.

Effect of exercise rehabilitation during neoadjuvant chemotherapy before esophageal cancer surgery on perioperative outcomes: A systematic review and meta-analysis.

Journal: Medicine
Published: July 09, 2025

METTL1 mediates m7G modification of PFKFB3 mRNA to promote radioresistance in esophageal cancer by affecting glycolytic metabolism.

METTL1 mediates m7G modification of PFKFB3 mRNA to promote radioresistance in esophageal cancer by affecting glycolytic metabolism.

Journal: Pathology, research and practice
Published: May 19, 2025

TFAP2A facilitates the metastasis and radioresistance of esophageal cancer by promoting EGFR transcription.

TFAP2A facilitates the metastasis and radioresistance of esophageal cancer by promoting EGFR transcription.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 26, 2024

RNA-seq analysis reveals key genes associated with downregulation of APE1 in esophageal squamous cell carcinoma.

RNA-seq analysis reveals key genes associated with downregulation of APE1 in esophageal squamous cell carcinoma.

Journal: Frontiers in genetics
Published: December 21, 2024

Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent Mechanism.

Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent Mechanism.

Journal: Drug development research
Published: August 07, 2024

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration.

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration.

Journal: Molecular biology reports
Published: August 01, 2024

Clinical evaluation of the convolutional neural network‑based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy.

Clinical evaluation of the convolutional neural network‑based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy.

Journal: Oncology letters
Published: March 04, 2024

Circ-POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR-876-5p/FYN axis.

Circ-POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR-876-5p/FYN axis.

Journal: Thoracic cancer
Published: January 05, 2024

Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.

Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.

Journal: Medicine
Published: December 20, 2023

Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.

Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.

Journal: Oncology letters
Published: November 22, 2023

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experience.

Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center's decade of experience.

Journal: Frontiers in oncology
Published: October 15, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026